Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 38,627 | 41,288 | 44,261 | 33,894 | 26,169 |
| Cost of Goods | 7,100 | 4,742 | 5,098 | 3,647 | 2,767 |
| Gross Profit | 31,527 | 36,546 | 39,163 | 30,247 | 23,402 |
| Operating Expenses | 82,824 | 85,587 | 66,622 | 49,083 | 35,226 |
| Operating Income | -51,197 | -48,299 | -27,361 | -18,189 | -11,057 |
| Interest Expense | 0 | 0 | 127 | 1,044 | 826 |
| Other Income | 10,142 | 10,376 | 3,917 | 151 | 66 |
| Pre-tax Income | -41,055 | -37,923 | -23,571 | -19,082 | -11,816 |
| Net Income Continuous | -41,055 | -37,923 | -23,571 | -19,082 | -11,816 |
| Net Income | $-41,055 | $-37,923 | $-23,571 | $-19,082 | $-11,816 |
| EPS Basic Total Ops | -0.39 | -0.37 | -0.23 | -0.21 | -0.17 |
| EPS Basic Continuous Ops | -0.39 | -0.37 | -0.23 | -0.21 | -0.17 |
| EPS Diluted Total Ops | -0.39 | -0.37 | -0.23 | -0.21 | -0.17 |
| EPS Diluted Continuous Ops | -0.39 | -0.37 | -0.23 | -0.21 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.37 | -0.23 | -0.21 | N/A |
| EBITDA(a) | $-53,124 | $-51,248 | $-27,330 | $-16,835 | $-10,013 |